In a murine breast tumor model, DCs loaded with tumor antigens and siRNA against IDO1 decreased the tumor size and the apoptosis of CD4+ and CD8+ T cells, when compared to DCs without IDO1 silencing [58]. Here, IDO1 is linked to breast neoplasm.